Israel’s Teva has launched a generic version of EXJADE (deferasirox) in the US. It treats patients two years of age and older for chronic iron overload due to blood transfusions. Currently, one in eight generic prescriptions dispensed in the U.S. is filled with a Teva generic product.

https://en.globes.co.il/en/article-teva-launches-generic-iron-overload-treatment-1001279327